Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

18 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Rituximab (anti-CD20) adjunctive therapy for opsoclonus-myoclonus syndrome.
Pranzatelli MR, Tate ED, Travelstead AL, Barbosa J, Bergamini RA, Civitello L, Franz DN, Greffe BS, Hanson RD, Hurwitz CA, Kalinyak KA, Kelfer H, Khakoo Y, Mantovani JF, Nicholson SH, Sanders JM, Wegner S. Pranzatelli MR, et al. Among authors: travelstead al. J Pediatr Hematol Oncol. 2006 Sep;28(9):585-93. doi: 10.1097/01.mph.0000212991.64435.f0. J Pediatr Hematol Oncol. 2006. PMID: 17006265
B cell depletion therapy for new-onset opsoclonus-myoclonus.
Pranzatelli MR, Tate ED, Swan JA, Travelstead AL, Colliver JA, Verhulst SJ, Crosley CJ, Graf WD, Joseph SA, Kelfer HM, Raju GP. Pranzatelli MR, et al. Among authors: travelstead al. Mov Disord. 2010 Jan 30;25(2):238-42. doi: 10.1002/mds.22941. Mov Disord. 2010. PMID: 20063398 Clinical Trial.
18 results